E-THERAPEUTICS’ new chief financial officer is Dr Daniel Elger, formerly vice-president of marketing at cancer drug developer Antisoma.
Elger has been involved in senior management and corporate strategy for a number of years, assisting with the acquisition of two US biotech companies and directing investor relations.
Chief executive Malcolm Young said: “Daniel has a wide set of skills across corporate, financial and communications areas, and he is a valuable addition to the e-Therapeutics team. Following our £21m placing at the beginning of the year, implementing our strategic plans and communicating them to current and potential shareholders will be key elements of his role.
Elger holds a BA in physiological sciences and a PhD in cancer cell biology, both from Oxford University.
Accountancy Age Jobs is delighted to announce the launch of a brand new look website for finance and accountancy professionals
The UK gender pay gap will not close until 2069 unless action is taken to tackle it now, according to new research by Deloitte
Three former Tesco executives, including the former finance director of Tesco UK, have been charged with fraud by the Serious Fraud Office in relation to a £263m accounting scandal at the retailer.
Deloitte chief executive David Sproul is among 11 chief executives to take part in global executive search firm Odgers Berndtson’s CEO for a Day scheme